Related Experiment Videos
Some aspects of androgen insensitivity.
Summary
Androgen insensitivity syndromes vary widely. A whole cell assay helps determine the cause, but classification doesn't always match clinical presentation. Further research is needed for receptor-positive cases.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Androgen insensitivity syndromes present a broad spectrum of clinical and endocrine features.
- The pathogenesis of these syndromes is often linked to androgen receptor dysfunction.
Purpose of the Study:
- To review the clinical and endocrine features of androgen insensitivity syndromes.
- To utilize a whole cell assay for studying androgen receptor binding in genital skin fibroblasts to determine the pathogenesis.
- To explore potential functional tests for androgen responsiveness.
Main Methods:
- Review of clinical and endocrine features of androgen insensitivity syndromes.
- Application of a dispersed whole cell assay using genital skin fibroblasts to assess androgen receptor binding.
- Analysis of in vitro study classifications against clinical sub-groups.
Main Results:
- In vitro studies using the whole cell assay showed that classification of androgen insensitivity disorders does not always align with clinical sub-groups.
- Androgen-induced augmentation of basal specific binding is proposed as a potential functional test for androgen responsiveness.
- The precise cause of androgen insensitivity in many receptor-positive patients remains undetermined, pending identification of DNA probes for the androgen receptor gene.
Conclusions:
- The study highlights the complexity of androgen insensitivity syndromes and the limitations of current in vitro assays in perfectly correlating with clinical phenotypes.
- A novel functional test for androgen responsiveness is proposed, offering potential for improved diagnosis and management.
- Further genetic research, specifically identifying DNA probes for the androgen receptor gene, is crucial for a comprehensive understanding of receptor-positive androgen insensitivity.